Oric Historical Cash Flow
| ORIC Stock | USD 6.14 0.15 2.38% |
Analysis of Oric Pharmaceuticals cash flow over time is an excellent tool to project Oric Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.1 M or Capital Expenditures of 1 M as it is a great indicator of Oric Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Oric Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Oric Pharmaceuticals is a good buy for the upcoming year.
Oric |
About Oric Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Oric balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Oric's non-liquid assets can be easily converted into cash.
Oric Pharmaceuticals Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Oric Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Oric Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Oric Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Oric Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oric Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.At present, Oric Pharmaceuticals' Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 1.9 M, whereas Total Cashflows From Investing Activities is projected to grow to (93.4 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 2.1M | 849K | 1.2M | 1.0M | Depreciation | 966K | 1.0M | 1.1M | 1.1M |
Oric Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Oric Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oric Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (216.0M) | 159.4M | (107.2M) | (43.4M) | 22.1M | 23.2M | |
| Change In Cash | (10.7M) | 148.0M | (159.2M) | (43.4M) | 36.0M | 37.8M | |
| Total Cashflows From Investing Activities | (768K) | (216.0M) | 158.4M | (109.2M) | (98.3M) | (93.4M) | |
| Other Cashflows From Financing Activities | (20.8M) | (866K) | 225K | 1.5M | 1.5M | 1.9M | |
| Depreciation | 970K | 897K | 966K | 1.0M | 1.1M | 1.1M | |
| Capital Expenditures | 667K | 939K | 2.1M | 849K | 1.2M | 1.0M | |
| Total Cash From Operating Activities | (45.3M) | (59.5M) | (75.1M) | (85.7M) | (112.7M) | (107.0M) | |
| Change To Operating Activities | 234K | (2.3M) | 1.1M | 1.0M | 1.2M | 1.2M | |
| Net Income | (73.7M) | (78.7M) | (89.1M) | (100.7M) | (127.8M) | (121.5M) | |
| Total Cash From Financing Activities | 250.5M | 49.1M | 25.6M | 85.7M | 126.5M | 88.9M | |
| End Period Cash Flow | 78.4M | 226.5M | 67.3M | 23.9M | 59.9M | 84.4M | |
| Change To Netincome | 1.1M | 25.4M | 12.9M | 14.5M | 16.7M | 10.0M | |
| Change To Liabilities | 986K | 4.3M | 2.9M | (1.5M) | (1.7M) | (1.6M) | |
| Sale Purchase Of Stock | 70.9M | 271.8M | 51.0M | 545K | 490.5K | 466.0K | |
| Stock Based Compensation | 5.3M | 12.9M | 14.5M | 15.2M | 20.2M | 10.9M | |
| Free Cash Flow | (45.9M) | (60.5M) | (77.2M) | (86.5M) | (112.7M) | (107.0M) | |
| Change In Working Capital | 2.0M | 4.1M | (445K) | 4.9M | 2.0M | 2.1M | |
| Begin Period Cash Flow | 89.2M | 78.4M | 226.5M | 67.3M | 23.9M | 22.7M | |
| Other Non Cash Items | 19.8M | 1.4M | (1.0M) | (6.1M) | (8.1M) | (7.7M) | |
| Issuance Of Capital Stock | 271.3M | 50M | 25M | 85M | 125M | 104.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oric Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.